110 related articles for article (PubMed ID: 12966886)
1. [Effect of gastrointestinal tract secretions on the anti-lysozyme activity of enterobacteria].
Tarasevich AV; Usviatsov BIa; Zykova LS
Zh Mikrobiol Epidemiol Immunobiol; 2003; (4):78-81. PubMed ID: 12966886
[TBL] [Abstract][Full Text] [Related]
2. [Effect of bifidobacteria on the anti-lysozyme activity of enterobacteria].
Valyshev AV; Elagina NN; Kirillov VA; Kirillov DA; Bukharin OV
Zh Mikrobiol Epidemiol Immunobiol; 2000; (4 Suppl):77-9. PubMed ID: 12712520
[TBL] [Abstract][Full Text] [Related]
3. [Effect of water-soluble vitamins on the anti-lysozyme activity of enterobacteria].
Valyshev AV; Kirillov VA; Kirillov DA
Zh Mikrobiol Epidemiol Immunobiol; 2000; (4 Suppl):80-2. PubMed ID: 12712521
[TBL] [Abstract][Full Text] [Related]
4. [Genetic determinants of secreted lysozyme inhibitors and enterobacteria anti-lysozyme phenotype].
Perunova NB; Andriushchenko SV; Bukharin OV
Zh Mikrobiol Epidemiol Immunobiol; 2012; (6):8-12. PubMed ID: 23297624
[TBL] [Abstract][Full Text] [Related]
5. [Modifying action of Saccharomyces boulardii on the biological properties of enterobacteria].
Kirillov DA; Perunova NB; Chelpachenko OE; Elagina NN; Valyshev AV; Bukharin OV
Zh Mikrobiol Epidemiol Immunobiol; 2002; (4):57-9. PubMed ID: 12449702
[TBL] [Abstract][Full Text] [Related]
6. [Antilysozyme activity and antibiotic resistance of periulcerous zone microflora in patients with gastric and duodenal ulcer].
Chervinets VM
Zh Mikrobiol Epidemiol Immunobiol; 2002; (1):73-6. PubMed ID: 11949263
[TBL] [Abstract][Full Text] [Related]
7. [Periplasmic lysozime inhibitior PliC and its role in antilysozime activity of enterobacteria].
Andryushenko SV; Perunova NB; Bukharin OV
Mikrobiologiia; 2014; 83(3):302-11. PubMed ID: 25844440
[TBL] [Abstract][Full Text] [Related]
8. [The heterogeneity of the antilysozyme activity in populations of opportunistic enterobacteria].
Gabrilovich IM; Boziev VB; Gabrilovich MI; Nagoev BS; Nakova LV; Usaeva IaS
Zh Mikrobiol Epidemiol Immunobiol; 1994; Suppl 1():32-3. PubMed ID: 7856344
[TBL] [Abstract][Full Text] [Related]
9. [Influence of chemical analogue of extracellular microbial autoregulators on antilysozyme activity of bacteria].
Bukharin OV; Perunova NB; El'-Registan GI; Nikolaev IuA; Iavnova SV; Molostov EV; Kirillov DA
Zh Mikrobiol Epidemiol Immunobiol; 2007; (6):3-6. PubMed ID: 18283730
[TBL] [Abstract][Full Text] [Related]
10. [The effect of inulin on the biological properties of enterobacteria].
Valyshev AV; Kirillov VA; Kirillov DA; Bukharin OV
Zh Mikrobiol Epidemiol Immunobiol; 2000; (1):79-80. PubMed ID: 10876903
[TBL] [Abstract][Full Text] [Related]
11. [Bacterial antilysozyme activity and its regulation by antibiotics].
Bukharin OV; Usiatsov BIa; Zykova LS; Malyshkin AP; Pervushina LA
Antibiot Med Biotekhnol; 1987 Aug; 32(8):597-602. PubMed ID: 3674841
[TBL] [Abstract][Full Text] [Related]
12. [The persistence factors of the enterobacteria in the fecal flora in intestinal dysbiosis].
Valyshev AV; Gil'mutdinova FG; Fomicheva SV
Zh Mikrobiol Epidemiol Immunobiol; 1996; (3):96-8. PubMed ID: 8771745
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of lysozyme by bile acids.
Vantrappen G; Ghoos AY; Peeters T
Am J Dig Dis; 1976 Jul; 21(7):547-52. PubMed ID: 941895
[TBL] [Abstract][Full Text] [Related]
14. [ACID-BASE MODULATION OF LYSOZYME ACTIVITY IN MEDIUM FOR CULTIVATION OF ENTEROBACTERIA].
Andryuschenko SV; Perunova NB
Zh Mikrobiol Epidemiol Immunobiol; 2015; (4):45-8. PubMed ID: 26470418
[TBL] [Abstract][Full Text] [Related]
15. [Comparative analysis of the sensitivity of enterobacteria to bile].
Gritsenko VA; Brudastov IuA; Kudria EV; Vasil'eva LI
Zh Mikrobiol Epidemiol Immunobiol; 2002; (3):65-7. PubMed ID: 12141044
[TBL] [Abstract][Full Text] [Related]
16. [Phasic changes in reproductive potential, intracellular polyamines and antilysozyme activity in Escherichia coli in periodic culture].
Bukharin OV; Gritsenko VA; Tkachenko AG; Salakhetdinova OIa
Mikrobiologiia; 2000; 69(1):132-4. PubMed ID: 10808501
[TBL] [Abstract][Full Text] [Related]
17. A study of some factors affecting the in-vitro release of drug from prolonged release granulations. 3. Effects of particle size, enzymatic contents of pepsin and pancreatin, bile and ionic concentration.
Asker AF; Motawi AM; Abdel-Khalek MM
Pharmazie; 1971 Apr; 26(4):215-7. PubMed ID: 4930110
[No Abstract] [Full Text] [Related]
18. [BIOLOGICAL PROPERTIES OF BACTERIA OF THE FAMILY ENTEROBACTERIACEAE AS COMPONENTS OF MICROSYMBIOCENOSIS OF THE FIRST INTERMEDIATE HOSTS OF O.FELINEUS].
Stepanova TF; Bukharin OV; Kataeva LV; Perunova NB; Karpukhina NF
Med Parazitol (Mosk); 2015; (4):3-7. PubMed ID: 26827577
[TBL] [Abstract][Full Text] [Related]
19. Proceedings: Bile acids inhibit lysozyme activity.
Ghoss Y; Vantrappen G; Peeters T
Gut; 1975 May; 16(5):394. PubMed ID: 1140642
[No Abstract] [Full Text] [Related]
20. [Screening of plasmids in the bacteria of the genus Bacillus with antilysozyme activity].
Bukharin OV; Kirillov DA; Kirillov VA
Zh Mikrobiol Epidemiol Immunobiol; 2006; (1):3-6. PubMed ID: 16532631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
